The pediatric heart transplant waitlist uses only three urgency categories, so less-sick children get hearts before sicker children and kids die waiting

The system that allocates donor hearts to children uses just three priority tiers: Status 1A (most urgent), Status 1B, and Status 2. A child's tier is determined by their diagnosis type (congenital heart disease vs. cardiomyopathy) and the medications they receive — not by a granular assessment of how sick they actually are. A 2024 Stanford Medicine study found that these three categories show significant overlap in mortality risk, meaning a child classified as Status 2 can be sicker and closer to death than a child classified as Status 1A. So what? Within each tier, children are ranked by wait time, not by medical acuity. If two children are both Status 1A, the one who has been waiting longer gets the next available heart — even if the newer listing is far more critically ill. This means a less-sick child who was listed three months ago will receive an organ before a child who was listed yesterday and is actively dying. The system cannot distinguish between 'stable on medication but technically Status 1A' and 'will die this week without a transplant.' So what? Pediatric heart transplant has the highest waitlist mortality of virtually any organ or age group. While mortality has fallen from 21% to 13% in recent years, that improvement came from advances in medical care (better medications, better mechanical support devices), not from better allocation. The allocation system itself is still failing to route hearts to the children who need them most urgently. Children are dying on the waitlist not because there are no hearts, but because the hearts are going to less-sick children who happened to be listed first. This problem persists because pediatric transplant is a small field with limited political leverage. Adult heart allocation was reformed in 2018 with a six-tier system that more granularly stratifies medical urgency, but the pediatric system was left behind. The pediatric transplant community is small, the patient population is small, and there is insufficient advocacy pressure to force OPTN to overhaul a system that technically 'works' but distributes organs suboptimally.